Anika Therapeutics (ANIK) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with introductions of board members, executive officers, independent auditor, and legal counsel.

• Stockholders participated via web portal and phone, with public listen-only access.

• Rules of conduct and procedures were made available, and the meeting was recorded for replay.

Board and executive committee updates

• Board members and committee chairs were introduced, including the Executive Chair, Lead Independent Director, and Audit and Compensation Committee Chairs.

• Inspector of Elections was appointed and sworn in for the meeting.

Shareholder proposals

• Five proposals were presented: election of three Class III directors, ratification of Deloitte & Touche LLP as auditor, advisory vote on executive compensation, amendment to the 2017 Omnibus Incentive Plan, and amendment to the 2021 Employee Stock Purchase Plan.

• Board unanimously recommended approval of all proposals.